Vitreoretinopathy, Proliferative
"Vitreoretinopathy, Proliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
Concept/Terms
Vitreoretinopathy, Proliferative- Vitreoretinopathy, Proliferative
- Proliferative Vitreoretinopathies
- Proliferative Vitreoretinopathy
- Vitreoretinopathies, Proliferative
Below are MeSH descriptors whose meaning is more general than "Vitreoretinopathy, Proliferative".
Below are MeSH descriptors whose meaning is more specific than "Vitreoretinopathy, Proliferative".
This graph shows the total number of publications written about "Vitreoretinopathy, Proliferative" by people in Harvard Catalyst Profiles by year, and whether "Vitreoretinopathy, Proliferative" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 1 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 4 | 0 | 4 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 5 | 0 | 5 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.
-
Proliferative Vitreoretinopathy: Pathophysiology and Therapeutic Approaches. Int Ophthalmol Clin. 2024 Apr 01; 64(2):125-135.
-
RESCUE INTRAVITREAL METHOTREXATE TREATMENT FOLLOWING EARLY RECOGNITION OF PROLIFERATIVE VITREORETINOPATHY. Retin Cases Brief Rep. 2023 Sep 01; 17(5):616-619.
-
Outcomes of Zone 3 Open Globe Injuries by Wound Extent: Subcategorization of Zone 3 Injuries Segregates Visual and Anatomic Outcomes. Ophthalmology. 2023 04; 130(4):379-386.
-
PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair. Br J Ophthalmol. 2023 04; 107(4):555-559.
-
Molecular Targets for Proliferative Vitreoretinopathy. Semin Ophthalmol. 2021 May 19; 36(4):218-223.
-
Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy. Sci Rep. 2020 11 30; 10(1):20554.
-
Novel Frizzled-4 Mutation Is Associated With Familial Exudative Vitreoretinopathy Mimicking Persistent Fetal Vasculature. J Pediatr Ophthalmol Strabismus. 2020 Jan 24; 57:e4-e7.
-
INCREASED COMPLEMENT LEVELS IN HUMAN VITREOUS ASPIRATES OF PROLIFERATIVE DIABETIC RETINOPATHY AND RETINAL DETACHMENT EYES. Retina. 2019 Nov; 39(11):2212-2218.
-
Indications, Findings, and Outcomes of Pars Plana Vitrectomy after Open Globe Injury. Ophthalmol Retina. 2020 02; 4(2):216-223.
-
Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells. Lab Invest. 2019 12; 99(12):1874-1886.